DiogenX

DiogenX is a biotechnology company focused on regenerating insulin-secreting β cells to treat diabetes. Its main project focuses on modulating the Wnt/β-catenin signaling pathway to regenerate insulin-producing β cells, providing a disease-modifying therapy for type 1 diabetes.